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A B S T R A C T
Lenticulostriate vasculopathy (LSV) is an ultrasound (US) visible lesion of the brain, which appears as echogenic
streaks or spots in the arteries of thalamus and basal ganglia. LSV has varied etiology. Transfontanelar Color Doppler
(TFCD) can easily display lenticulostriatal blood flow and assess: stage I LSV with present flow within echogenic chan-
ges and stage II LSV in which the flow disappears, despite a presence of streaks and spots, which at this stage most proba-
bly correspond to calcification. The objectives of this study are to determine: (1) Whether there are differences in distribu-
tion (unilateral or bilateral) and presence (during first year of age) of TFCD flow between congenital CMV infection
positive and negative group of children with LSV; (2) Could US and TFCD findings of LSV be an indication for further
investigation of possible congenital CMV infection, because of their variable and often adverse neurodevelopmental out-
come? We examined and followed-up 98 infants with LSV. One group (37/98) with congenital CMV infection and second
(61/98) negative. All infants had clinical signs of neuromotor delay and ultrasound and TFCD markers of LSV. Our
study shows that most of the patients from both groups had TFCD visible flow at the age of 0–4 months. In majority of
them in both groups, at the age of 5–8 months, there was no more visible flow. TFCD showed no statistically significant
difference among congenital CMV infection positive group and negative group, nor in youngest age period (0–4 months),
nor in later course of flow in LSV, unilaterally or bilaterally. Although the LSV presents nonspecific marker for intra-
cranial infection (ICI), all infants presenting with LSV should be evaluated for possible ICI. Thus, the Doppler findings
of LSV in infants require a detailed examination, monitoring and follow-up of neuromotor outcome.
Key words: congenital cytomegalovirus infection, CMV, lenticulostriate vasculopathy, Transfontanelar Color Dopp-
ler (TFCD), brain ultrasound (US)
Introduction
Lenticulostriate vasculopathy (LSV) is an ultrasound
(US) visible lesion of the brain, which appears as echo-
genic streaks or spots in the arteries of thalamus and
basal ganglia1–8. The lenticulostriate arteries are perfo-
rating branches of the middle cerebral arteries (MCA).
The MCA area is the most frequent location of neonatal
cerebral infarction. Whether there is any association be-
tween LSV and neonatal cerebral infarction, it is still un-
known. LSV is registered with ultrasound in 0.27 to 2.5%
of live-born infants, in 3.2 to 5.1% of premature infants
and 1.9 to 5.8% of ill newborns2–8. It can be unilateral or
bilateral, appear on ultrasound as echoic vertical »strip-
-like«, branched or dotted shape, and pathohistological
examination proved that they correlate with small and
medium-sized lenticulostriate arteries9. It was first de-
scribed in the year 1960, after rubella epidemic in Phi-
ladelphia10. Post mortal histological analysis of infant
brain showed signs of vasculitis. For unknown reasons,
the pathological lesions were localized exclusively in the
arteries of the basal ganglia and thalamus10. Grant et al.
first described the ultrasound findings of these lesions11
and after him, Teele performed an ultrasound examina-
tion in 4500 children in the Children’s Hospital Boston
and registered congenital cytomegalovirus (CMV), ru-
bella and syphilis infection and trisomy 13 with no signs
of infection12. Brain biopsy was done which showed baso-
philic deposit with mineralization and hypercellularity of
small and medium-sized arteries. So, Teele first conclu-
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ded that focal vasculopathy found histologicaly, corre-
sponds to the changes registered on intracranial ultra-
sound examination12. LSV has varied etiology and it can
be found in cases of infection, hemorrhage, hypoxic-
-ischemic encephalopathy, infarction, hypoglycemia, cal-
cification, vascular lesion or chromosomal aberrations,
and also it may be registered in healthy children11–16.
Transfontanelar Color Doppler (TFCD) can easily dis-
play lenticulostriatal blood vessels, their localization,
size and number, and in the gray scale, using spectral
analysis of the systole, diastole, mean velocity and resis-
tance index in the real time, blood flow within them can
be shown. On the basis of these findings LSV stage can
be assessed: stage I LSV with present flow within echo-
genic changes and stage II LSV in which the flow disap-
pears, despite a presence of streaks and spots, which at
this stage most probably correspond to calcification.
The objectives of this study are to determine:
1. Whether there are differences in distribution (unilat-
eral or bilateral) and presence (during first year of
age) of TFCD flow between congenital CMV infection
positive and negative group of children with LSV;
2. Could US and TFCD findings of LSV be an indication
for further investigation of possible congenital CMV
infection, because of their variable and often adverse
neurodevelopmental outcome?
Patients and Methods
During the period of 4 years, from 1st January 2003 to
31st December 2006 in 218 infants, referred to our Clinic
due to deviant neurodevelopmental milestones with or
without perinatal risk factors, ultrasound registered echo-
genic streaks and spots, unilateral or bilateral, diagnosed
as LSV. In all of them, CMV serological test and PCR
were performed in the Clinic for Infectious Diseases in
order to prove or exclude congenital CMV infection. Of
these 218 children, 56 children were positive for congeni-
tal CMV infection (25.7%), and 162 negative (74.3%). In
37 of 56 children positive on congenital CMV infection,
and in 61 of 162 negative children, detailed TFCD and
follow-up was performed, and included in the study con-
stituting a total number of 98 infants. All included chil-
dren had their first TFCD performed at the age 0–4
months, with follow-up at the age of 5–8 months, and in
case of still positive flow in hyperechogenicities, addi-
tional follow-up examination was performed at the age of
9–12 months of age. In case of negative LSV flow in the
first examination, TFCD follow-up was still performed at
the age of 5–8 months in order to verify the lack of flow.
In two children from CMV negative group, hyperechoge-
nicities were no longer visible on US at the age of 5–8
months of age and they were classified as negative flow
in the follow-up. The remaining number of children (120
of 218) with US markers of LSV were excluded from
TFCD study because of insufficient data and lost in fol-
low-up.
Thus, in this study we examined and followed-up
Doppler parameters in 98 children with LSV, divided into
two groups: congenital CMV positive and congenital CMV
negative group. Within each group, first TFCD examina-
tion at the age of 0–4 months was further characterized
and distributed into three groups depending on localiza-
tion and presence of flow: unilateral, bilateral and nega-
tive flow in LSV. We did not analyze the number of echoic
lesions, meaning that children presenting with either mi-
nor (one or two spots unilaterally), moderate or major
LSV (according to El-Ayoubi et al.) were all included into
this study17. Subject of this study was not the number of
US determined lesions, but distribution and presence of
TFCD flow within them unilaterally or bilaterally. We
compared TFCD findings, determined Doppler phase of
LSV, duration and transition of phase.
The data were presented as the absolute and relative
numbers (percentages). c2-test was used in the data anal-
ysis, while in cases that where the expected frequency in
more than 20% of all cells was under 5, Fisher’s exact
test was used. The data were analysed with the Simple
Interactive Statistical Analysis (SISA; available at http://
www.quantitativeskills.com/sisa/). The significance was
set at p<0.05.
Results
We examined and followed-up a total number of 98
children with LSV. One group consisted of 37 infants
with congenital CMV infection, and second group con-
sisted of 61 infants negative for congenital CMV infec-
tion. All children had clinical signs of neuromotor delay
and ultrasound markers of LSV with dotted or vertical
hyperechogenicities in thalamus and basal ganglia of the
brain (Figure 1a and b). US findings of hyperechogenici-
ties were various: some infants had only spots, some only
vertical and some had combined hyperechogenicities lo-
calized unilaterally or bilaterally, or in the thalamus and
basal ganglia. In this paper we did not analyze the num-
ber and appearance of the LSV, but only their existence
and localization. TFCD was performed in all included
children to visualize the blood vessels in the echogenic
area, and real time spectral analysis verified flow in sys-
tole and diastole, with the mean velocity and resistance
index which was equivalent to lenticulostriate vasculo-
pathy (Figure 2a and b).
In the congenital CMV infection positive group, con-
sisted of 37 infants, TFCD flow in LSV was seen at the
age of 0–4 months in 32/37 (86.48%) infants, 8 unilateral
(21.62%), 24 bilateral (64.86%), and correlated most pro-
bably to lenticulostriate artery vasculopathy, or stage I
LSV. In remaining 5/37 infants (13.51%) of the same age
period, TFCD flow was absent, suggesting stage II LSV.
At the age of 5–8 months, TFCD flow was still visible in
10/37 infants, 3 unilateral (8.11%), 7 bilateral (18.92%),
while in most infants 27/37 was negative (72.97%), sug-
gesting stage II LSV, most likely because of obliteration
or calcification. After that period, at the age of 9–12
months, TFCD was performed only in 10 infants that
had visible flow at the age of 5–8 month, and only 1 in-
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fant still had visible flow, while in all remaining 9/10 in-
fants flow was undetectable (Table 1).
In the congenital CMV infection negative group the
same protocol was used. In 49/61 (80.32%) infants, the
flow was registered in the first 4 months of life, 10 unilat-
eral (16.39%), 39 bilateral (63.93%), while remaining 12
infants (19.67%) did not have visible flow in the same age
period. At the age of 5–8 months, TFCD flow was still visi-
ble in 9/61 infants, 3 unilateral (4.92%), 6 bilateral (9.84%),
while in most infants 52/61 was negative (85.25%). In 9/61
infants with visible flow, TFCD follow-up was performed
at the age of 9–12 months and 8 of them had negative
flow, while only one displayed with still visible flow (Ta-
ble 2). In both groups majority of patients had bilateral
TFCD flow, 24/37 in congenital CMV positive group, and
39/61 in congenital CMV negative group (Figure 3).
The analysis of CMV positive and negative samples
revealed the lack of significant differences (c2=0.61,
d.f.=1, p=0.435; Table 1, Table 2). Following, stratified
analysis of the 0–4 months age group revealed no signifi-
cant differences in unilateral (c2=0.42, d.f.=1, p=0.517)
or bilateral lesions (c2=0.01, d.f.=1, p=0.926). There
were no differences in the 5–8 months year old children as
entire group (c2=2.22, d.f.=1, p=0.136), nor in unilateral
(Fisher’s exact p=0.858) or bilateral lesions (p=0.164).
Lastly, we detected no significant difference in 9–12
months old children (Fisher’s exact p=0.737; Table 1,
Table 2, Figure 3).
Discussion
Our study of 98 patients with LSV, 37 positive for con-
genital CMV infection and 61 negative, shows that most
of the patients from both groups had TFCD visible flow
at the age of 0–4 months. Majority of them in both
groups, at the age of 5–8 months, had no more visible
flow. Smaller part of patients with still visible flow, 10 in
congenital CMV infection positive group and 9 in CMV
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Fig. 2a (above) and 2b (below). TFCD real time spectral analysis
showing flow in systole and diastole, with the mean velocity and
resistance index. Figure below showing no more visible flow in
hyperechoic lesions.
TABLE 1
CONGENITAL CMV INFECTION POSITIVE GROUP
Congenital CMV positive group
Transfontanelar Color Duplex Doppler
0–4 months old (37 patients) 5–8 months old (37 patients) 9–12 months old (10 patients)*
Unilateral flow Bilateral flow Negative flowUnilateral flow Bilateral flow Negative flow Unilateral flow Bilateral flow Negative flow
8 24 5 3 7 27 1 0 9
21.62% 64.86% 13.51% 8.11% 18.92% 72.97% 10% 0.00% 90%
* patients with still visible flow from the previous age period
Fig. 1a (above) and 1b (below). Ultrasound markers of LSV with
hyperechoic streaks and spots and TFCD visualization of blood
vessels in the echogenic area.
negative group, had their follow-up performed at the age
of 9–12 months, and the flow was still visible in only one
patient from each group. Based on presence of TFCD vis-
ible flow in echogenic streaks and spots, LSV was catego-
rized in two stages: stage I LSV with present flow and
stage II LSV without flow. Stage does not reflect the age
of the patient, since both negative and positive flow was
found in the first 4 months of life, but rather course of
pathological changes in the vasculature of thalamus and
basal ganglia. Once negative, TFCD flow remained nega-
tive throughout following period of age. In none of the
patients stage II LSV did not change to stage I LSV, sug-
gesting that when at a certain point stage I LSV became
stage II, it remained stable. From this study, we can not
conclude with certainty that LSV always has stage I, fol-
lowed by stage II, because in 17 patients (5 from congeni-
tal CMV positive group, and 12 from negative group) had
negative flow (stage II LSV) in the youngest age, 0–4
months. But given the progressive changes in LSV in ma-
jority of other patients, we can speculate that those 17
patients had stage I LSV earlier in development, prior to
the TFCD examination, suggesting possibility of earlier
congenital infection.
TFCD verifies the vascular nature of echogenic spots
and streaks on the basis of pulsating arterial flow within
them. Neuropathological basis for the ultrasound visible
LSV and why the gangliothalamic arteries are involved is
still unclear. It corresponds to mineralization, deposits of
calcium and iron, hypercellular walls of the arteries,
perivascular infiltrates and micronodules, as well as ba-
sophilic deposits in the walls of arteries12,18. Various fac-
tors have been reported to be associated with LSV. Dur-
ing many years the highest incidence was reported for
mainly TORCH infections, but gradually other condi-
tions were reported having LSV, as well as in healthy in-
fants without any apparent abnormality6,9,19.
Our result of 25.7% of patients with LSV being posi-
tive for congenital CMV infection, is higher than previ-
ously reported but we presume that the reasons for that
are: selected patients referred to clinic because of peri-
natal risk factors and/or deviant neuromotor develop-
ment1,6,9,14,15,17. Our population does not represent gen-
eral population. In our study there were no resources to
screen and diagnose other possible causes of LSV in con-
genital CMV infection negative group, but we agree with
Wang et al. proposition of LSV as a marker of diffuse in-
sult to the fetal and neonatal brain20. Since brain US
and/or TFCD are non-invasive, relatively highly avail-
able and non-expensive neuroimaging method if com-
pared to brain CT and MR, they represent a tool of choice
for diagnosis of LSV. Previous studies suggested that it is
not »cost-effective« to screen for congenital CMV infec-
tion in cases of isolated LSV without any other signs of
abnormality1,5,6,17. We would like to annex that in cases of
LSV finding in selected population of infants, with clini-
cal signs of neuromotor impairment and/or perinatal risk
factors, it is recommended to screen for CMV.
In our study, TFCD showed no statistically significant
difference among congenital CMV infection positive group
and negative group, nor in youngest age period (0–4
months), nor in later course of flow in LSV, unilaterally
or bilaterally. TFCD negative flow in the youngest age re-
mained negative in the following period, suggesting per-
manent and stable changes to vascular architecture. Al-
though TFCD did not improve diagnosing of congenital
CMV infection, it is important and highly sensitive tool
for verifying vascular nature of lesions. LSV staging
might provide insight into more precise timing of con-
genital CMV infection, in case of serological confirma-
tion, but such TFCD use needs to be further investigated
in larger and prospective study.
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Fig. 3. Showing both group comparison of total number, unilat-
eral, bilateral and negative flow in all patients during infancy.
No statistically significant difference was found.
TABLE 2
CONGENITAL CMV NEGATIVE GROUP
Congenital CMV negative group
Transfontanelar Color Duplex Doppler
0–4 months old (61 patient) 5–8 months old (61 patient) 9–12 months old (9 patients)*
Unilateral flow Bilateral flow Negative flow Unilateral flow Bilateral flow Negative flow Unilateral flow Bilateral flow Negative flow
10 39 12 3 6 52 0 1 8
16.39% 63.93% 19.67% 4.92% 9.84% 85.25% 0.00% 11.11% 88.89%
* patients with still visible flow from the previous age period
Conclusion
In the first phase of the LSV, TFCD registered flow in
the arteries, which disappeared after 4 months of age in
most infants. There was no statistically significant dif-
ference in distribution (unilateral or bilateral) between
CMV positive and CMV negative group. Also there was
no statistically significant difference in presence of TFCD
flow during first year of age between CMV positive and
CMV negative group of children with LSV. Although the
LSV presents an nonspecific marker for intracranial in-
fection (it can be found also in other conditions such as
metabolic disorders, chromosomal aberrations and con-
genital anomalies, and in healthy children), given the
fact that 25.7% of children with LSV along with clinical
signs of neuromotor impairment and/or perinatal risk
factors were positive for congenital CMV infection, all in-
fants presenting with LSV and deviant neurodevelop-
ment should be evaluated for possible intracranial infec-
tion.
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LENTIKULOSTRIJATUSNA VASKULOPATIJA – SLIKOVNI MARKER KONATALNE
CITOMEGALOVIRUS INFEKCIJE?
S A @ E T A K
Lentikulostriatalna vaskulopatija (LSV) je ultrazvu~no (UZV) vidljiva lezija mozga koja se prikazuje ehogenim tra-
kama i to~kama u arterijama talamusa i bazalnih ganglija. LSV ima raznoliku etiologiju. Transfontanelarni kolor Dop-
pler (TFCD) mo`e dobro prikazati lentikulostriatalne krvne `ile i procijeniti: stadij I LSV-a s prisutnim protokom u
ehogenostima i stadij II LSV-a kada protoka vi{e nema, unato~ i dalje prisutnim hiperehogenostima koje u to vrijeme
najvjerojatnije odgovaraju kalcifikacijama. Ciljevi ovog rada su ustanoviti postoje li razlike u distribuciji (jednostrano ili
obostrano) i prisutnosti protoka (tijekom prve godine `ivota) u TFCD nalazu protoka izme|u skupina djece pozitivne i
negativne na kongenitalnu CMV infekciju te mogu li UZV i TFCD nalazi biti indikacija za daljnju dijagnostiku mogu}e
kongenitalne CMV infekcije zbog njezinog varijabilnog i ~esto nepovoljnog utjecaja na neurorazvojni ishod. U ovoj stu-
diji smo pratili 98 dojen~adi s LSV-om. Jedna grupa (37/98) s kongenitalnom CMV infekcijom, a druga grupa (61/98)
negativna. Svi ispitanici su imali klini~ke znakove neuromotornog zaostajanja te UZV i TFCD znakove LSV-a. Na{a
studija je pokazala da je ve}ina djece u obje grupe imala vidljiv protok na TFCD-u u dobi do 4 mjeseca. U ve}ine iz obje
grupe, u dobi 5–8 mjeseci, vi{e nije bilo vidljivog protoka. TCFD nije pokazao nikakve statisti~ke razlike izme|u dvije
skupine, niti u najranijem periodu, niti u kasnijem tijeku LSV-a, unilateralno ili bilateralno. Iako LSV predstavlja
nespecifi~an marker za intrakranijsku infekciju uzev{i u obzir da je 25.7% djece s LSV-om te neurorazvojnim odstupa-
njem, pozitivno na kongenitalnu CMV infekciju, svi s nalazom LSV-a uz perinatalne rizi~ne faktore bi trebali procjenu
radi mogu}e kongenitalne CMV infekcije.
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